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Streptococcus pyogenes possesses a wide variety of virulence factors and can cause severe invasive
infections. Most S. pyogenes express surface-located ﬁbronectin-binding proteins as major invasion
molecules. We identiﬁed 2 novel ﬁbronectin-binding proteins (FbaA and FbaB) in S. pyogenes isolated
from patients with severe invasive infection. Fba-deﬁcient mutant strains showed signiﬁcantly lower
efﬁciency of invasion of human epithelial cells than that shown by an isogenic wild type strain.
Furthermore, compared to mice infected with the isogenic wild-type strains, those infected with
fba-deﬁcient mutant strains showed decreased mortality. These ﬁndings suggest that Fba proteins are
the causative agents for the development of severe invasive S. pyogenes infections.
We know that few neutrophils migrate to S. pyogenes in severe streptococcal infection. We also
found that complement C3b is degraded in the sera of patients with severe invasive S. pyogenes
infections. Furthermore, it is now known that S. pyogenes SpeB is able to fragment neutrophil
extracellular traps (NETs). SpeB appears to contribute to the escape of bacterial organisms from
neutrophils by inactivating C3b and degrading NETs at the site of initial infection.
Moreover, we have identiﬁed a C6-binding protein in cell-surface protein fractions from S. pyogenes. C6 is
a component of the complement membrane attack complex (MAC). The C6-binding protein contributes to
S. pyogenes evasion of the complement system by inhibiting MAC polymerization and bacteriolysis activity.
We have conﬁrmed that S. pyogenes is equipped with a wide variety of virulence factors to invade human
tissue and escape from immunity.
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Group A Streptococcus pyogenes is an important gram-positive
bacterial pathogen that causes a wide variety of clinicalciation for Oral Biology. Publishedconditions, ranging from pharyngitis to severe invasive infections
and necrotizing fasciitis. The reported lethality of severe
S. pyogenes infections is high, ranging from 10%–30% [1]. The death
toll from these severe infections is estimated to be at least 650,000
each year [2]. Therefore, our research and this review are focused
on S. pyogenes in order to elucidate aspects of the infection.
As shown in Fig. 1, it is understood that all S. pyogenes
infections are initiated by adhesion of the bacterial organism toby Elsevier B.V. All rights reserved.
(Terao et al., J. Biol. Chem., 2006)
(Terao et al., J. Biol. Chem., 2002) 
(Terao et al., Infect. Immun., 2002)
(Terao et al., J. Infect. Dis., 2005)
(Ogawa, Terao et al., FEMS Microb. Lett., 2011)
(Ogawa, Terao et al., Microb. Pathog.,  2011) 
(Terao et al., J. Biol. Chem., 2008)
(Kawabata et al., BBRC., 2002)
(Okamoto et al., FEMS Microb. Lett., 2008)
(Terao et al., Mol. Microbiol., 2001)
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Fig. 1. Proposed pathogenesis of severe Streptococcus pyogenes infection.
Y. Terao / Journal of Oral Biosciences 54 (2012) 96–100 97human epithelial cells, including those in the oral and nasal
cavities and the skin. Bacterial pathogens express various mole-
cules that are anchored in the cell wall as ﬁmbrial-like structures.
Several surface ﬁmbrial-like proteins also bind to human extra-
cellular matrix proteins, including ﬁbronectin (Fn) [3], laminin
[4], and collagen [5]. The Fn-binding proteins of S. pyogenes were
identiﬁed and characterized between 1993 and 2002. The
Fn-binding proteins have also been reported to be adhesion
factors and invasion factors. The Fn-binding proteins include
protein F1 [6], SfbI [7], protein F2 [8], SfbII [9], SOF [10], PFBP
[11], FbaA [12,13], and FbaB [14]. Interestingly, each Fn-binding
protein is expressed and distributed in a particular group of M
serotype organisms [6,11]. Highly virulent serotypes of S. pyo-
genes strains express one or more Fn-binding proteins. Serotype
M1 and M49 strains possess FbaA, and serotype M6 and M12
strains produce protein F1/SfbI. However, in serotypes M3 and
M18 strains, which are also reported as highly virulent strains, no
Fn-binding proteins were identiﬁed until we recognized FbaB as
an Fn-binding protein in M3 and M18, after which we showed
that this protein was only expressed among aggressively infec-
tious isolates. Serotype M3 and M18 strains are major serotypesthat have been isolated from patients with severe invasive disease
[1,14]. Thus, we hypothesized that FbaB protein is associated with
more durable pathogenic capabilities.
After initial invasion of human tissues, it is reported that
S. pyogenes can spread rapidly to various organs. We have con-
jectured that S. pyogenes escapes from the human immune system,
enabling the organisms to initiate systemic and severe infections.
Recently, it was reported that fewer neutrophils migrated to sites
of S. pyogenes infection [15]. The complement system has central
and important roles in innate immunity, which acts as a protective
system in the early phases of infection. In innate immunity,
complement C3b is the most important opsonin and complement
C5a is the most important chemotaxis factor, and they also
integrate activation of the classical, alternative, and lectin-binding
pathways. ScpA is a C5a-speciﬁc serine protease on the surface of S.
pyogenes [16]. However the C5a-cleavage mechanism was unclear.
In our research, we have investigated how S. pyogenes traps C5a
molecules on the cell surface for degradation by cell-associated
ScpA. Using in silico methods and genome sequencing databases,
we identiﬁed a gene encoding the C5a-binding protein. Further-
more, we found that the C5a-binding protein is completely
Y. Terao / Journal of Oral Biosciences 54 (2012) 96–10098consistent with streptococcal plasmin receptor (Plr) [17], strepto-
coccal surface dehydrogenase (SDH) [18], and glyceraldehyde
3-phosphate dehydrogenase (GAPDH) [19]. Now SDH and GAPDH
have been shown to be the same molecule as Plr, and these
ﬁndings suggest that the multifunctional GAPDH in S. pyogenes
has distinct functions for inhibiting the host immune system.2. Adhesion to and invasion of host tissues: the initial step of
S. pyogenes infection
2.1. FbaA in serotype M1 strains
The M1 strain of S. pyogenes is a major serotype that has been
isolated throughout the world from patients with severe invasive
diseases. We sought and identiﬁed invasion factors from
S. pyogenes. The invasins of S. pyogenes are expressed on the
bacterial surface and bind to human Fn. We searched for
LPXTG-containing proteins in a S. pyogenes genome database.
The LPXTG motif is the most well known cell-anchoring motif in
gram-positive bacteria, including S. pyogenes [20–23]. Gram-
positive bacterial invasins commonly possess this motif. In our
search, we found several unknown LPXTG-motif-containing pro-
teins from the serotype M1 S. pyogenes genome database [11].
One putative LPXTG-motif-containing protein possessed an Fn-
binding domain. We constructed a recombinant protein and
investigated its binding to human Fn using a ligand-blot analysis.
Our results showed that the recombinant protein bound to Fn,
and we termed it FbaA (ﬁbronectin-binding protein of group A
streptococci type A).
We next analyzed the function of the FbaA protein in the
process of bacterial infection. A constructed-fbaA-deﬁcient
mutant strain was subjected to bacterial adhesion assay using
Fn-coated microtiter plates. The binding activities were quantiﬁed
using rabbit anti-S. pyogenes polyclonal antibody and increasing
densities of organisms. The wild type strain of S. pyogenes bound
to Fn in a density dependent manner, and the binding of the fbaA-
deﬁcient mutants was lower than that of the isogenic wild type
strain. These results demonstrated that Fn-binding proteins work
as Fn-binding proteins and adhesins on the surface of live
S. pyogenes. To analyze the further function of FbaA protein in
S. pyogenes, the invasion efﬁciency of the fbaA-deﬁcient mutant
strain was investigated in human epithelial cell lines. The fbaA-
deﬁcient mutant strain exhibited lower invasion efﬁciencies than
the isogenic wild type strain in the epithelial cells.2.2. FbaB in serotype M3 strains
A number of M3 strains of S. pyogenes are also isolated from
patients with severe invasive infections. When clinical isolates of
serotype M3 strains were tested by labeled-Fn for expression of
Fn-binding proteins, several isolates from severe invasive infec-
tions, but not the strains from mild pharyngitis and impetigo,
expressed the Fn-binding protein FbaB [13].
To determine the role of FbaB proteins in M3 strains, the
adhesion and invasion efﬁciencies of the wild type strain and the
isogenic fbaB-deﬁcient mutant strain were compared in human
epithelial cells. The adhesion and invasion efﬁciencies of the fbaB-
deﬁcient mutant strain were decreased compared with the wild
type strain. Fluorescent microscopic examination revealed that
the adhesion and invasion activities of the fbaB-deﬁcient mutant
strain were clearly reduced compared to the isogenic wild type
strain. These results indicated that FbaB serves as both an adhesin
and an invasin of epithelial cells. Deletion of FbaB proteins results
in reduced mouse mortality even though infected with a lethaldose of S. pyogenes. This also suggests that FbaB contributes to the
virulence of serotype M3 S. pyogenes strains (Fig. 1).
Fba proteins appear to have essential roles in S. pyogenes
invasion of human cells associated with severe invasive disease.
The virulence factors that allow the spread of S. pyogenes to
deeper tissues are now under investigation in our laboratory, and
our ﬁndings are described the next section.3. Spread to deep tissues: escape from the immune system
3.1. Complement C3b-degrading protease from S. pyogenes
Since it has been observed in most cases of invasive S. pyogenes
infection that there is no inﬁltration of neutrophils around the
organism at the site of infection, we speculated that S. pyogenes
inactivated the human immune system, including complement
immunity. We then examined whether S. pyogenes isolated from
severe invasive infections could degrade complement molecules.
Western blot analysis revealed that culture supernatant from
S. pyogenes cleaved human complement C3 and C3b. C3b is a
complement fragment from C3 and it plays an important role in the
complement system by recruiting on the bacterial surfaces to
promote opsonization. Western blotting with anti-C3b showed that
C3b was not present in the sera of patients with severe invasive
infections, whereas it was clearly detected by western blotting in
sera from healthy volunteers,. Therefore, we set out to identify a
C3b-degrading protease among the S. pyogenes proteases [24].
It is reported that S. pyogenes possesses 3 major proteases
[1,15], one of which is an extracellular cysteine protease, SpeB
[16,25], and another that is a cell-associated serine protease [26].
We investigated the ability of recombinant SpeB to degrade C3b
in healthy human serum. Fig. 3A shows that puriﬁed human C3b
was degraded by SpeB. In contrast, other recombinant proteases
from S. pyogenes could not cleave C3b.
We next examined the survival rates of a wild-type strain and
the isogenic speB-deﬁcient mutant strain in human blood. After
3 h incubation of bacteria with blood, the wild type strain
survived at a signiﬁcantly higher rate than the isogenic
speB-deﬁcient mutant strain. In a mouse model, bacterial survival
rate was also lower for the isogenic speB-deﬁcient mutant strain
compared with the isogenic wild type strain. Furthermore, histo-
pathological examination showed that neutrophils migrated to
the site of infection with the isogenic speB-deﬁcient mutant
strain, whereas few migrated to the infection site in mice injected
with the wild type strain, which continued to spread along the
fascia. Moreover, time-lapse microscopic analysis revealed that
digestion of neutrophil extracellular traps (NETs) was accom-
plished by the wild-type strain, but not the isogenic speB-
deﬁcient mutant strain (Fig. 2).
The secreted SpeB protease appears to function as an inacti-
vator of the complement system through degradation of C3b in
blood and activity as a NET-cleaving enzyme.
3.2. Complement C5a-inhibitors from S. pyogenes
The absence of neutrophil migration to S. pyogenes sites in
severe invasive infections also prompted us to search for
C5a-inhibitors in S. pyogenes. Complement C5a is known to act
as a chemotaxin and to recruit neutrophils to the site of infection.
Ligand blot analysis with labeled-C5a detected a 36-kDa protein
on the surface of S. pyogenes. We determined the amino acid
sequence of this protein. The sequence revealed that the
C5a-binding protein is identical to Plr, SDH, and GAPDH [27].
We constructed recombinant GAPDH and investigated
C5a-binding activity by ligand blotting. The analysis revealed that
200 nm
MAC
CM
CW
200 nm
Fig. 3. High-speed atomic force microscopy analysis of C6-binding protein on the bacterial surface. The live S. pyogenes strain was immobilized on the mica grid and
observed by high-speed atomic force microscopy after addition of complement solutions. (A) Atomic force microscopy (AFM) images of complement-polymerization on the
surface of the c6bp-deﬁcient mutant strain (arrow). After 600 s of incubation with complement, the c6bp-deﬁcient mutant strain was lysed from the MAC-pore (arrow).
(B) A line drawing identifying the AFM images. Abbreviations: MAC, membrane attack complex; CW, cell wall; CM, cytosolic membrane.
S. pyogenes
(wild type)
+ neutrophils
S. pyogenes
(speB-deficient)
+ neutrophils
0 10 20 min
Fig. 2. Neutrophil extracellular trap—degrading activity of Streptococcus pyogenes. Time-lapse microscopic analysis of Streptococcus pyogenes interaction with neutrophil
extracellular traps NETs. Human neutrophils were suspended in RPMI 1640 medium supplemented with 2% human serum and 25 nM PMA, and S. pyogenes organisms were
added to the mixture. Upper panels, NETs were digested in the presence of the wild-type S. pyogenes strain. Lower panels, the speB-deﬁcient mutant strain did not
degrade NETs.
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of GAPDH to enhance C5a cleavage on the surface of S. pyogenes.
We found that blocking GAPDH or ScpA with speciﬁc antibodies
inhibited C5a cleavage. This result suggests that GAPDH can
enhance the C5a-degrading activity of ScpA protease from
S. pyogenes. Furthermore, when we investigated the effects of
GAPDH on C5a-induced chemotaxis of neutrophils, the recombi-
nant GAPDH signiﬁcantly decreased chemotactic activity gener-
ated by C5a.
3.3. Complement membrane attack complex-inhibitors from
S. pyogenes
The complement membrane attack complex (MAC) consists of
complements C5b to C9 and leads bacteriolysis, which results
from polymerization and pore formation on the bacterial surface.
We identiﬁed a C6-binding protein in cell-surface protein frac-
tions from S. pyogenes by ligand blotting with labeled-C6, and
then we constructed a recombinant C6-binding protein and the
c6bp-deﬁcient mutant strain. Interaction between C6 and the C6-
binding protein was determined using a Biacore system. In
addition, high-speed atomic force microscopy was utilized to
visualize the process of bacteriolysis by the MAC and the
inhibitory effect of the C6-binding protein. The Biacore analysis
demonstrated that the C6-binding protein bound more rapidly to
C6 than C7, C8, and C9. Furthermore, the atomic force microscopy
observations showed that C6-binding protein inhibited MAC
polymerization and bacteriolysis at the nanoscale level on the
bacterial surface. Brieﬂy, it was noted that the complementfragments were polymerized on the surface of the c6bp-deﬁcient
mutant strain after 120 s incubation with complement solutions,
and the c6bp-deﬁcient mutant strain was lysed from the MAC-
pore after 600 s of incubation with complement (Fig. 3). It was
also observed that complements bound to the bacterial surface of
the wild type strain. However, no MAC-pore was visible on the
surface of the wild type organism. After 600 s, there was no
bacteriolysis in the ﬁeld of view.
These results indicate that C6-binding protein contributes to
the escape of S. pyogenes from the complement system by
inhibiting MAC polymerization.4. Conclusions
S. pyogenes is a gram-positive microorganism that causes mild
infections of the throat and skin. More recently, it has also been
reported that S. pyogenes can cause severe invasive infections
[1,2]. The ﬁrst step of S. pyogenes infection is bacterial adhesion to
and invasion of human epithelial cells via Fn. Fn-binding proteins
of S. pyogenes have been identiﬁed and we have investigated their
role in the invasion of epithelial cells. However, the mechanisms
by which S. pyogenes escapes from human immunity and how it
grows in human blood and tissues remained unclear. Our research
and this review have aimed to more clearly identify the virulence
factors of S. pyogenes and to better understand the mechanisms
associated with development of severe S. pyogenes infections.
We ﬁrst investigated novel virulence factors of S. pyogenes
using genome databases. It is well known that bacteria invade
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possess Fn-binding proteins. From 1993–2002, several cell wall-
associated proteins of S. pyogenes were reported to bind to Fn
[6–13]. Each Fn-binding protein is expressed among a particular
group of M serotypes, and highly virulent M serotype strains
possess one or more Fn-binding proteins. Serotype M1 and M3
strains are major serotypes that have been isolated throughout
the world from patients with severe invasive infections, yet there
was no report that M1 and M3 strains possessed Fn-binding
proteins. We hypothesized that there should be novel Fn-binding
proteins in serotype M1 or M3 group A strep (GAS) organisms that
are associated with the high virulence. We conducted several
experiments that demonstrated that serotype M1 strains express
FbaA protein and M3 strains have FbaB protein on their cell
surfaces. We demonstrated that FbaA contributes to the survival
of S. pyogenes in the infected host by binding with human factor H
and factor-H-like protein 1. We have investigated the mechan-
isms of Fn-binding and localization on the surface of S. pyogenes in
detail. In addition, we have shown that FbaA protein may be a
vaccine candidate against S. pyogenes infection.
In the phase following bacterial invasion into human tissues,
S. pyogenes must evade human innate immunity, which functions
as the initial protective barrier against pathogens. Neutrophils
and complement play major roles in innate immunity, and the
complement activation products C3b and C5a play central roles
in complement immunity. We have demonstrated that the
S. pyogenes GAPDH protein allows evasion of the complement
system by blocking C5a. Following bacterial invasion, GAPDH
works together with C5a peptidase from S. pyogenes to allow the
bacteria to escape detection by neutrophils, which can explain the
lack of neutrophil migration to the sites of invasive infection.
Since the mechanisms by which S. pyogenes evaded the ﬁrst line
of host defense was still unclear, in additional studies, we also
sought and identiﬁed a C3b-cleaving protease and a MAC inhibit-
ing factor from S. pyogenes.
Our results have contributed more to the understanding of
how S. pyogenes causes severe invasive infections. Further study
of S. pyogenes virulence factors should continue to clarify the
mechanisms involved with invasive infections [28–30].Conﬂict of interest
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